Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

EMBC - Embecta Corp. Stock Price, Fair Value and News

$11.96-1.34 (-10.08%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

EMBC Price Action

Last 7 days

8.0%

Last 30 days

15.3%

Last 90 days

-23.9%

Trailing 12 Months

29.1%

EMBC RSI Chart

AugSepOctNovDec2025FebMarAprMay0102030405060708090

EMBC Valuation

Market Cap

770.9M

Price/Earnings (Trailing)

13.25

Price/Sales (Trailing)

0.7

EV/EBITDA

31.75

Price/Free Cashflow

26.67

EMBC Price/Sales (Trailing)

2023202420250.511.52

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

EMBC Fundamentals

EMBC Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

-5.55%

Rev. Growth (Qtr)

-8.46%

20212022202320241.08B1.1B1.12B1.14B1.16B

EMBC Earnings

Earnings (TTM)

58.2M

Earnings Growth (Yr)

-100%

Earnings Growth (Qtr)

-100%

20212022202320240100M200M300M400M

EMBC Profitability

EBT Margin

2.64%

Return on Equity

-7.57%

Return on Assets

5.06%

Free Cashflow Yield

3.75%

EMBC Investor Care

Dividend Yield

4.52%

Dividend/Share (TTM)

0.6

Shares Dilution (1Y)

0.96%

Diluted EPS (TTM)

0.99

Revenue Breakdown

As of: Dec 31, 2024
2024AprJulOct190M195M200M205M210M
Pen Needles
ProductValuePercent
GeographyValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.1B1.1B1.1B1.1B
20231.1B1.1B1.1B1.1B
20221.2B1.2B1.1B1.1B
20211.1B1.1B1.2B1.2B
2020001.1B1.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
 CEO
 WEBSITEembecta.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES1900

Embecta Corp. Frequently Asked Questions

What is the ticker symbol for Embecta Corp.? What does EMBC stand for in stocks?

EMBC is the stock ticker symbol of Embecta Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Embecta Corp. (EMBC)?

As of Thu May 08 2025, market cap of Embecta Corp. is 770.86 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EMBC stock?

You can check EMBC's fair value in chart for subscribers.

Is Embecta Corp. a good stock to buy?

The fair value guage provides a quick view whether EMBC is over valued or under valued. Whether Embecta Corp. is cheap or expensive depends on the assumptions which impact Embecta Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EMBC.

What is Embecta Corp.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 08 2025, EMBC's PE ratio (Price to Earnings) is 13.25 and Price to Sales (PS) ratio is 0.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EMBC PE ratio will change depending on the future growth rate expectations of investors.